Liver Biome+ · 1,800+ studies
Probiotic Blend (10B CFU)
Live bacterial strains — Lactobacillus acidophilus, Bifidobacterium lactis and Lactobacillus rhamnosus — included for the gut–liver axis, the two-way traffic between intestinal barrier function and hepatic load.
The form we use
Enteric-protected multi-strain consortium, 10 billion CFU
Probiotics only matter if they arrive alive. Stomach acid is the documented barrier, which is why the strains are enteric-protected to reach the lower intestine intact, and why CFU count is stated at a defined point rather than left ambiguous. Multi-strain rather than single-strain reflects how the gut–liver literature is structured.
Why this form
How the common forms compare
| Form | What published literature reports | In TruWe |
|---|---|---|
| Single-strain probiotic | Simple and well characterised, but narrower than the multi-strain designs used in gut–liver research. | Not used |
| Multi-strain, enteric-protected | Designed so strains survive gastric transit and reach the lower intestine. | Used |
| Unprotected probiotic powder | Gastric acid exposure is the documented obstacle to viable delivery. | Not used |
| Fermented-food only | Valuable dietary source, but strain identity and dose are not defined. | Not used |
Dose
Where it appears, and how much
Liver Biome+
10 Billion CFU
L. acidophilus, B. lactis, L. rhamnosus
View product →
The evidence
What the research says
Multi-strain L. acidophilus, B. lactis, L. rhamnosus — for gut barrier integrity and microbial diversity.
Reference researcher: Prof. Mary Ellen Sanders · International Scientific Association for Probiotics & Prebiotics
- Expert consensus document: the ISAPP consensus statement on the scope and appropriate use of the term probiotic
Nature Reviews Gastroenterology & Hepatology · 2014
- Thirty years of Lactobacillus rhamnosus GG: a review
Journal of Clinical Gastroenterology · 2019
- Effects of probiotics on non-alcoholic fatty liver disease: a meta-analysis
World Journal of Gastroenterology · 2013
Questions, answered
Probiotic Blend (10B CFU) FAQ
- What is the gut–liver axis?
- The circulatory and immune link between the intestine and the liver. Intestinal barrier function influences what the liver has to process.
- Does the tablet need refrigeration?
- No. The strains are stabilised and enteric-protected for shelf storage; keep it cool, dry and out of direct sunlight.
- Is 10 billion CFU enough?
- CFU count matters less than strain identity and survival to the site of action, which is why the strains are named and enteric-protected.
- Can I take it with antibiotics?
- Space them apart and follow your doctor's advice for your specific course.
Ingredient-level research is published on the individual actives and their delivery forms. It describes the ingredients, not a finished-product claim. These statements have not been evaluated by the FSSAI or FDA. This content is for information only and is not medical advice.
← All ingredients
